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1.	Introduction	
	
Much	attention	has	been	focused	on	the	heterocyclic	drugs	
agents	 includes	 sulfur‐containing	 compounds	 have	 broad‐
spectrum	 activities,	 such	 as	 antimalarial	 [1],	 HIV‐1	 inhibitors	
[2],	 and	 antimicrobial	 [3].	 5,6‐Dihydro‐4H‐1,3‐thiazines	 were	
synthesized	 as	 cholecystokinin	 antagonists	 [4]	 or	 antimyco‐
bacterial	 [5].	 Heterocyclic	 compounds	 containing	 on	 the	
thiazine	 includes	 carbon	 and	 nitrogen	 atoms	 and	 one	 sulfur	
atom	in	different	locations	on	the	six‐membered	ring	in	there	is	
1,2‐;	 1,3‐;	 1,4‐thiazines	 [6‐8]	 and	 include	 derivatives	 were	
synthesized	 NCS	 binding	 to	 use	 antibacterial,	 antimicrobial,	
insects,	 anti‐tumor,	 fungal,	 and	agents	herbicides,	 and	various	
colorants	 etc.	 [9‐19].	 1,3‐Thiazines	 derivatives	 are	 used	 in	
preparation	 of	 various	 organic	 [20].	 Here,	 we	 report,	
researcher	 concentrates	on	 the	different	 synthetic	procedures	
in	addition	to	the	biological	activities	of	1,3	thiazines	and	their	
derivatives.	
	
2.	Experimental	
	
2.1.	Instrumentation	
	
Melting	 points	were	 determined	with	 an	 Electro	 Thermal	
Mel‐Temp	II	apparatus	and	were	uncorrected.	IR	spectra	(KBr)	
were	recorded	on	a	FT	IR‐8201	PC	spectrophotometer.	1H	NMR	
was	measured	with	a	Varian/Gemini	200	MHz	spectrometer	in	
DMSO‐d6	as	a	solvent	and	chemical	shifts	were	recorded	in	(δ,	
ppm).	 Mass	 spectra	 were	 recorded	 on	 an	 instrument	 "VG‐
7035".	 Spectra	 were	 recorded	 at	 70	 or	 15	 eV.	 Elemental	
analysis	 was	 performed	 at	 the	Micro	 Analytical	 Centre,	 Cairo	
University,	Giza,	Egypt.	
	
2.2.	Synthesis	
	
2.2.1.	Ethyl	2,6‐diamino‐4H‐thieno[3,2‐d][1,3]thiazine‐7‐
carboxylate	(2)	
	
A	 mixture	 of	 compound	 1	 (0.01	 mol),	 ethylcyanoacetate	
(0.01	mol),	sulfur	(0.01	mol)	and	diethylamine	(0.01	mol)	was	
heated	 (70	 °C)	 with	 stirring	 in	 absolute	 ethanol	 for	 4	 h.	
According	to	Gewald	et	al.	[21],	then	the	mixture	was	leaved	for	
24	h	at	0	 °C.	The	 solid	was	 filtrated,	washed	with	ethanol	 (20	
mL),	 dried	 and	 crystallized	 from	 absolute	 ethanol	 to	 give	
yellow	crystals	(Scheme	1).	Yield:	64%.	M.p.:	267‐269	°C.	FT‐IR	
(KBr,	ν,	cm‐1):	3420	(NH2)	(amine),	2917	(CH)	(aliphatic),	1718	
(CO)	(ester).	1H	NMR	(200	MHz,	DMSO‐d6,	δ,	ppm):	1.58	(t,	3H,	
CH3),	 2.49	 (q,	 2H,	 CH2CH3),	 4.08	 (s,	 2H,	 SCH2),	 4.52	 (brs,	 2H,	
NH2),	7.73	(brs,	2H,	NH2).	Anal.	calcd.	for	C9H11N3O2S2	(257.33):	
C,	42.01;	H,	4.31;	N,	16.33;	S,	24.92.	Found:	C,	42.21;	H,	4.33;	N,	
16.36;	S,	24.95%.		
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Scheme	1	
	
	
2.2.2.	2‐Amino‐7‐thioxo‐7,8‐dihydro‐4H‐pyrimido[5',4':4,5]	
thieno[3,2‐d][1,3]thiazin‐9(6H)‐one	(3)	
	
Compound	2	(10	mmol)	fusion	with	thiourea	(10	mmol)	at	
180	°C	in	oil	bath	for	5	h,	added	the	ethanol	to	solidify	and	then	
filtration	the	solid,	dried,	and	recrystallized	from	ethanol	as	the	
solvent	to	give	compound	3	(Scheme	2).	Yield:	75%.	M.p.:	290‐
292	 °C.	 FT‐IR	 (KBr,	 ν,	 cm‐1):	 3340	 (NH),	 1665	 (C=O),	 1260	
(C=S).	1H	NMR	(200	MHz,	DMSO‐d6,	δ,	ppm):	3.44	(s,	2H,	CH2),	
6.83	 (brs,	 2H,	NH2),	9.30	 (s,	 1H,	NH,	 exchangeable	with	D2O),	
10.0	 (s,	 1H,	 NH,	 exchangeable	 with	 D2O).	 Anal.	 calcd.	 for	
C8H6N4OS3	(270.35):	C,	35.54;	H,	2.24;	N,	20.72;	S,	35.58.	Found:	
C,	35.38;	H,	2.36;	N,	20.68;	S,	35.62%. 
	
2.2.3.	6‐Amino‐2‐(2`,3`,4`‐tri‐O‐acetyl‐β‐L‐rhamnopyranosyl	
thio)‐9‐thia‐1H‐7‐thia‐1,3,5‐triazafluoren‐4‐one	(4)	
	
To	solution	of	compound	3	(1	mmole)	in	KOH	(0.73	g	in	10	
mL	 of	 distilled	 water),	 was	 added	 to	 2,3,4‐tri‐o‐acetyl‐α‐L‐
rhamnopyranosyl	bromide	(1	mmole)	in	acetone	(30	mL).	After	
the	mixture	was	stirred	for	72	hr	at	room	temperature,	then	the	
reaction	 complete	 and	 monitored	 by	 TLC.	 The	 mixture	 was	
filtered	 and	 the	 residue	 washed	 with	 water	 to	 remove	 the	
potassium	 bromide.	 The	 residue	 was	 purified	 by	 silica	 gel	
column	chromatography	using	eluent	ethanol/ethyl	acetate	 to	
afford	a	pale	yellow	crystal	(Scheme	2).	Yield:	80%.	M.p.:	246‐
248	 °C.	 FT‐IR	 (KBr,	 ν,	 cm‐1):	 3344	 (NH),	 1736	 (C=	 O),	 1604	
(C=N),	 523	 (C‐S).	 1H	 NMR	 (200	MHz,	 DMSO‐d6,	 δ,	 ppm):	 6.52	
(brs,	2H,	NH2),	5.82	(d,	1H,	H‐1`),	5.12	(m,	2H,	H‐5`,H‐5``),	4.32‐	
4.47	(m,	3H,	H‐2`,3`,4`),	3.17	(s,	2H,	CH2),	2.03	(s,	3H,	CH3),	1.90‐
2.13	 (3s,	 9H,	 3OAc).	 Anal.	 calcd.	 for	 C20H22N4O8S3	 (542.61):	 C,	
44.07;	H,	 4.09;	N,	 10.33;	 S,	 17.73.	 Found:	 C,	 44.27;	H,	 4.34;	N,	
10.52;	S,	17.81%. 
	
2.2.4.	General	procedure	for	preparation	of	compounds	5	
and	9	
	
Compounds	4	 and	8	 were	 dissolved	 in	 dry	methanol	 and	
dry	ammonia	gaseous	was	passed	through	the	stirred	solution	
for	 1‐2	 hrs.	 The	 solutions	were	 concentrated	 and	 the	 residue	
was	recrystallization	from	methanol‐petroleum	ether	(Scheme	
2).	
6‐Amino‐2‐(β‐L‐rhamnopyranosylthio)‐9‐thia‐1H‐7‐thia‐1,3,	
5‐triazafluoren‐4‐one	 (5):	 Yield:	 45%.	M.p.:	 259‐263	 °C.	 FT‐IR	
(KBr,	ν,	cm‐1):	3324	(NH),	1604	(C=N),	523	(C‐S).	1H	NMR	(200	
MHz,	DMSO‐d6,	δ,	 ppm):	7.26	 (s,	 1H,	NH),	7.12	 (brs,	2H,	NH2),	
5.82	(d,	1H,	H‐1`),	4.28	(s,	1H,	OH‐4`),	4.65	(1s,	2H,	OH‐3`,	2`),	
5.12	 (m,	 1H,	 H‐5`),	 4.32‐	 4.47	 (m,	 3H,	 H‐2`,3`,4`),	 3.17	 (s,	 2H,	
CH2),	2.21	(s,	3H,	CH3).	Anal.	calcd.	for	C14H16N4O5S3	(416.5):	C,	
40.37;	H,	 3.87;	N,	 13.45;	 S,	 23.10.	 Found:	 C,	 40.39;	H,	 3.97;	N,	
13.65;	S,	23.23%.	
7‐(5‐(β‐L‐rhamnopyranosylthio)‐1,3,4‐oxadiazol‐2‐yl)‐4H‐
thieno[3,2‐d][1,3]	 thiazine‐2,6‐diamine	 (9):	 Yield:	 65%.	 M.p.:	
239‐242	 oC.	FT‐IR	 (KBr,	ν,	 cm‐1):	3324	 (NH),	1624	 (C=N),	525	
(C‐S).	1H	NMR	(200	MHz,	DMSO‐d6,	δ,	ppm):	7.12	(brs,	2H,	NH2),	
6.34	(brs,	2H,	NH2),	5.70	(d,	1H,	H‐1`,	J1`,2`	=	8.2	Hz),	4.21	(s,	1H,	OH‐
4`),	4.39	(s,	2H,	OH‐3`,	2`),	5.02	(m,	1H,	H‐5`),	4.22‐	4.47	(m,	3H,	H‐
2`,3`,4`),	 3.09	 (s,	 2H,	 CH2),	 2.05	 (s,	 3H,	 CH3).	 Anal.	 calcd.	 for	
C14H17N5O5S3	 (431.51):	 C,	 38.97;	 H,	 3.97;	 N,	 16.23;	 S,	 22.29.	
Found:	C,	39.07;	H,	3.87;	N,	16.45;	S,	22.10%.	
	
2.2.5.	2,6‐Diamino‐4H‐thieno[3,2‐d][1,3]thiazine‐7‐
carbohydrazide	(6)	
	
A	 solution	 of	 the	 ester	2	 (2.6	 g,	 10	mmol)	 and	 hydrazine	
hydrate	 (0.6	 mL,	 99%)	 was	 refluxed	 in	 50	 mL	 of	 absolute	
ethanol	 for	 5	 hr.	 Then	 the	 solid	 was	 filtered	 off	 and	
recrystallized	from	EtOH/DMF	to	give	the	compound	6	as	white	
powder	(Scheme	3).	Yield:	76%.	M.p.:	235‐237	°C.	FT‐IR	(KBr,	ν,	
cm‐1):	3310,	3222,	3145	(NH,	NH2),	1631	(C=O),	1588	(C=N).	1H	
NMR	 (200	 MHz,	 DMSO‐d6,	 δ,	 ppm):	 9.02	 (brs,	 2H,	 NH2,	 D2O‐
exchangeable),	9.85	(brs,	1H,	NH,	D2O‐exchangeable),	7.45	(brs,	
2H,	 NH2),	 6.45	 (brs,	 2H,	 NH2),	 3.15	 (s,	 2H,	 CH2).	Anal.	 calcd.	 for	
C7H9N5OS2	(243.31):	C,	34.55;	H,	3.73;	N,	28.78;	S,	26.36.	Found:	
C,	34.96;	H,	3.52;	N,	28.76;	S,	26.15%.	
	
2.2.6.	5‐(2,6‐Diamino‐4H‐thieno[3,2‐d][1,3]thiazin‐7‐yl)‐
1,3,4‐oxadiazole‐2‐thiol	(7)	
	
A	mixture	of	compound	6	(0.01	mol)	and	carbon	disulfide	
(5	mL)	was	refluxed	in	pyridine	(25	mL)	for	8	h,	then	allowed	
to	 cool.	 The	 product	 was	 formed	 and	 recrystallized	 from	
ethanol	 as	 yellow	 crystals	 (Scheme	 3).	 Yield:	 63%.	M.p.:	 195‐
197	°C.	FT‐IR	(KBr,	ν,	cm‐1):	3222,	3145	(NH2),	2860‐2760	 (S‐
H),	 1588	(C=N).	1H	NMR	(200	MHz,	DMSO‐d6,	δ,	ppm):	9.02	(br.	
s,	2H,	NH2,	D2O‐exchangeable),	 6.89	 (brs,	2H,	NH2),	3.27	 (s,	2H,	
CH2),	3.05	(s,	1H,	C‐SH).	Anal.	calcd.	for	C8H7N5OS3:	(285.37):	C,	
33.67;	H,	 2.47;	N,	 24.54;	 S,	 33.71.	 Found:	 C,	 33.96;	H,	 2.52;	N,	
24.76;	S,	33.55%.	
	
2.2.7.	7‐(5‐(2',3',4'‐Tri‐O‐acetyl‐β‐L‐rhamnopyranosylthio)‐
1,3,4‐oxadiazol‐2‐yl)‐4H‐thieno[3,2‐d][1,3]	thiazine‐2,6‐
diamine	(8)	
	
A	mixture	of	compound	7	(10	mmol)	in	dry	DMF	(20	mL),	
NaH	 (15	mmol)	was	added	portion	wise	 through	15	min.	 and	
the	solution	stirred	at	room	temperature	for	30	min.	
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Scheme	3
	
	
Then,	 a	 solution	 of	 2,3,4‐tri‐o‐acetyl‐α‐L‐rhamnopyranosyl	
bromide,	in	DMF	(10	mL)	was	dropped	within	30	min.	and	the	
mixture	 was	 stirred	 at	 room	 temperature	 for	 12	 h.	 After	
completion,	 the	water	was	 added	 to	 the	 reaction	mixture	 and	
acidified	 with	 diluted	 acetic	 acid.	 The	 organic	 layer	 was	
extracted	with	 ethyl	 acetate	 (20	mL),	washed	with	water	 and	
dried	 over	 anhydrous	 sodium	 sulphate	 and	 evaporation	 the	
solvent	 to	 give	 a	 residue,	 which	 was	 purified	 by	 column	
chromatography	using	ethylacetate/ethanol	as	a	solvent	to	give	
compound	8	 (Scheme	 3).	 Yield:	 72%.	M.p.:	 210‐212	 °C.	 FT‐IR	
(KBr,	ν,	cm‐1):	3410,	3222,	3145	(NH,	NH2),	1731	(C=O),	1568	
(C=N).	1H	NMR	(200MHZ,	δ,	DMSO‐d6):	7.82	(brs,	2H,	NH2),	6.52	
(brs,	2H,	NH2),	4.86	(d,	1H,	H‐1`,	J1`,2`	=	9.5	Hz),	5.02	(m,	1H,	H‐
5`),	4.02‐4.23	(m,	3H,	H‐2`,3`,4`),	3.03	(s,	2H,	CH2),	2.23	(d,	3H,	
CH3,	 J5`,6`	 =	 7.3	 Hz),	 1.90‐2.01	 (3s,	 9H,	 3×OAc).	 Anal.	 calcd.	 for	
C20H23N5O8S3	 (557.62):	 C,	 43.08;	 H,	 4.16;	 N,	 12.56;	 S,	 17.25.	
Found:	C,	43.07;	H,	4.37;	N,	12.45;	S,	17.10%.	
2.2.8.	2,6‐Diamino‐4H‐thieno[3,2‐d][1,3]thiazine‐7‐phenyl	
hydrazinecarbothioamide	(10)	
	
A	mixture	 of	 compound	6	 (2.43	 g,	 10	 mmol)	 and	 phenyl	
isothiocyanate	 (9	mmol)	was	 refluxed	 in	absolute	ethanol	 (50	
mL)	 for	 5	 h,	 cooled	 and	 filtration.	 The	 solid	 was	 dried	 and	
recrystallized	from	ethanol	(Scheme	4).	Yield:	84%.	M.p.:	205‐
209	°C.	FT‐IR	(KBr,	ν,	cm‐1):	3237‐3121	(NH2,	NH),	1682	(C=O),	
1598,	1548,	1495	(C=C,	C=N),	1358‐1385	(C=S),	1293	(S‐CH2),	
1118	(C‐O).	1H	NMR	(200	MHz,	DMSO‐d6,	δ,	ppm):	3.98	(s,	2H,	
SCH2),	 7.18‐7.20	 (dd,	 2H,	 phenyl),	 7.32‐7.37	 (m,	 3H,	 phenyl),	
9.50	(s	br,	1H,	NH‐Ph),	9.75	(s,	1H,	NHCS),	10.29	(s,	1H,	CONH);	
4.13	(s,	2H,	NH2),	3.45(	s,	2H,	NH2).	Anal.	calcd.	for	C14H14N6OS3	
(378.5):	C,	44.43;	H,	3.73;	N,	22.20;	S,	25.42.	Found:	C,	44.23;	H,	
3.70;	N,	22.24;	S,	25.21%.	
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Scheme	4
	
	
2.2.9.	2,6‐diamino‐N'‐(4‐oxo‐3‐phenylthiazolidin‐2‐ylidene)‐
4H‐thieno[3,2‐d][1,3]thiazine‐7‐carbohydrazide	(11)	
	
A	 mixture	 of	 compound	 10	 (0.37	 g,	 1	 mmol),	 sodium	
acetate	 (0.29	 g,	 4	mmol)	 and	 ethyl	 bromoacetate	 (0.16	 g,	 1.1	
mmol)	was	 refluxed	 in	 absolute	 ethanol	 (15	mL)	 for	 3	 h.	 the	
solvent	was	removed	under	reduced	pressure,	the	residue	was	
washed	with	water	 and	extracted	with	 chloroform.	The	white	
solid	 was	 crystallized	 from	 2‐propanol	 to	 give	 compound	 11	
(Scheme	4).	Yield:	83%.	M.p.:	190‐189	°C.	FT‐IR	(KBr,	ν,	cm‐1):	
3229	(NH),	1669	(C=O),	1593,	1553,	1506	(C=C,	C=N),	1295	(S‐
CH2),	1119	(C‐O‐C).	1H	NMR	(200	MHz,	DMSO‐d6,	δ,	ppm):	4.15	
(s,	 2H,	 SCH2),	 4.07	 (s,	 2H,	 thiazolidine),	 6.86	 (d,	 2H,	 phenyl),	
7.15	(t,	1H,	phenyl),	7.38	(t,	2H,	phenyl),	8.32	(s,	1H,	NH),	7.21	
(s,	 2H,	 NH2),	 7.21	 (s,	 2H,	 NH2).	 Anal.	 calcd.	 for	 C16H14N6O2S3	
(418.52):	C,	45.92;	H,	3.37;	N,	20.08;	S,	22.98.	Found:	C,	45.72;	
H,	3.33;	N,	20.28;	S,	22.67%.		
	
2.3.	Antimicrobial	activity	
	
A	loop	full	of	the	given	bacterial	strain	was	inoculated	into	
25	mL	of	N‐broth	(Nutrient	Broth)	and	incubated	for	24	hr,	 in	
an	 incubator	 at	30	 °C	 in	order	 to	 activate	 the	bacterial	 strain.	
Petri‐dish	of	15	cm	diameter	was	filled	with	100	mL	of	nutrient	
agar	media.	 	 Vaccination	was	 carried	 out	 by	 the	 technique	 of	
molding	panel.	There	has	been	made	a	full	preparation	of	a	hole	
in	the	plywood	airflow	to	maintain	the	state‐sterile	and	aseptic	
strict.	After	the	consolidation	of	the	media,	 the	porosity	 in	 the	
media	with	the	help	of	perforated	cup	(10	mm),	and	0.1	mL	of	
concentration	(10	mg/1	mL)	of	the	different	compounds	tested	
was	 transferred	 into	 the	 well.	 Dimethylforamide	 (DMF)	 was	
used	as	a	control.	The	plates	were	incubated	for	24	hours,	at	30	
°C.	 Inhibition	 zone	 formed	 by	 synthetic	 compounds	 the	 test	
bacterial	 strain,	 especially	 to	 determine	 the	 antibacterial	
activities	of	the	compounds	tested	different	[22].	
Media	 Czepak	 Docs	 used	 to	 grow	 the	 types	 of	 fungi.	 The	
medium	 was	 seeded	 with	 different	 fungal	 species.	 After	
hardening	 of	 the	media	 on	 the	 sheets,	 and	make	 pores	 in	 the	
agar	 with	 a	 glass	 poorer	 (10	 mm)	 diameter,	 then	 was	
transferred	0.1	mL	of	 concentration	 (10	mg/1	mL)	of	 various	
synthetic	 compounds	 in	 the	 well.	 It	 has	 been	 used	 DMF	 as	 a	
control.	 The	 plates	 were	 incubated	 for	 5	 days	 at	 30	 °C.	
Inhibition	 zone	 formed	by	 the	 tested	 compounds	 to	 combat	 a	
certain	 strain	 experiments	 to	 determine	 the	 activities	 of	 anti‐
fungal	as	the	vehicles	tested	different	[23].	
	
3.	Results	and	discussion	
	
3.1.	Chemistry	
	
2‐Amino‐5,6‐dihydro‐1,3‐thiazin‐4‐one	 (1)	 was	 synthe‐
sized	from	the	reaction	of	thiourea	with	3‐bromopropionic	acid	
[24]	 (Scheme	 1).	 Compound	 1	 was	 reacted	 with	 ethyl	
cyanoacetate	in	ethanol	in	the	presence	of	diethylamine	to	yield	
ethyl	2,7‐diamino‐4H‐thieno[3,2‐d][1,3]	thiazine‐6‐carboxylate,	
2	 (Scheme	 1).	 The	 IR	 spectrum	 of	 compound	 2	 showed	
absorption	bands	at	3420	cm‐1	due	to	NH2.	
Ethyl	 2,7‐diamino‐4H‐thieno[3,2‐d][1,3]thiazine‐6‐carbo‐
xylate	(2)	was	fused	with	thiourea	in	absent	solvent	at	180	°C	
to	give	the	compound	thiopyrimidine	derivative	3.	Compound	3	
was	 combined	 with	 2,3,4‐tri‐o‐acetyl‐α‐L‐rhamnopyranosyl	
bromide	 [25]	 in	 the	 presence	 of	 potassium	 hydroxide	 and	
ethanol	 as	 the	 solvent	 to	 give	 the	approved	 compound	4.	 The	
subsequent	 removal	 of	 the	 protecting	 groups	 by	 treatment	 of	
compound	4	with	ammonia	gas	in	dry	methanol,	gave	the	final	
required	S‐glycoside,	5	(Scheme	2).		
The	 reaction	 of	 compound	2	 with	 hydrazine	 hydrate	 was	
refluxed	with	ethanol	afforded	the	carbohydrazide	derivative	6.	
Its	 IR	 spectra	 showed	 the	 appearance	 of	 three	 absorption	
bands	due	to	NH2	and	NH	functions	in	addition	to	the	carbonyl	
absorption	 band.	 Its	 mass	 spectrum	 showed	 a	 peak	
corresponding	to	its	molecular	ion	at	m/z	243	(M+).	
The	carbohydrazide	6	was	refluxed	with	carbon	disulfide	in	
the	 presence	 of	 pyridine	 yielded	 oxadiazoyltheinothiazine	
derivative	7,	 which	was	 combined	with	 2,3,4‐tri‐o‐acetyl‐α‐L‐
rhamnopyranosyl	 bromide	 in	 the	presence	of	 sodium	hydride	
and	 dimethylformamide	 to	 provide	 the	 corresponding	 S‐
glycoside,	 8.	 Deacetylation	 of	 the	 S‐nucleoside	 8	 proceeded	
with	methanolic	 ammonia	 to	 tolerate	 the	 free	nucleoside	9	 in	
good	yields	(Scheme	3).	The	structures	of	compounds	8	and	9	
were	created	by	IR	and	1H	NMR.	
Compound	 6	was	 refluxed	 with	 phenyl	 isothiocyanate	 in	
absolute	ethanol	gave	the compound	hydrazinecarbothioamide	
10	 a	 good	 yields.	 The	 compound	 10	 has	 been	 confirmed	 by	
spectral	 data.	 The	 infrared	 spectrum	 of	 compound	 10	
appearance	 characteristic	 absorption	 bands	 in	 a	 region	 of	
3237‐3121	cm‐1	for	NH,	at	1682	cm‐1	for	C=O	and	in	the	region	
of	1358‐1385	cm‐1	corresponding	to	C=S	vibrations.	Compound	
10	 was	 reacted	 with	 ethyl	 bromoacetic	 acid	 in	 existence	
absolute	ethanol	 in	the	presence	of	anhydrous	sodium	acetate	
as	a	base	to	produce	the	compound	of	4‐thiazolidinones	11.		
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Table	1.	Screening	for	antimicrobial	activity	of	the	tested	compounds.	
Inhibition	zone	diameter	(mm/mg	sample)	*Sample	no	
C.	albicans A.	flavusS.	aureus	(G+)E.	coli	(G−) 
7 879 2 
6 769 3 
4 7410 4 
6 769 5 
6 5712 7 
9 10108 8 
6 1588 9 
8 7811 10 
7 897 11 
‐ ‐232 Chloramphenicol 
10 18‐‐ Amphotericin	B 
*	 The	 concentration	 of	 the	 solution	 20.0	 mg/mL	 was	 tested.	 (G‐):	 Gram	 negative	 bacteria;	 (G+):	 Gram	 positive	 bacteria;	 E.	 coli:	 Esherichia	 coli;	 S.	 aureus:	
Staphylococcus	aureus;	A.	flavus:	Aspergillus	flavus;	C.	albicans:	Candida	albicans.	
	
	
Thiazolidinones	11	show	absorption	bands	for	ring	C=O	in	
the	region	of	1760	cm‐1	together	with	amide	C=O	absorption	at	
1670	cm‐1.	The	1H	NMR	spectrum	revealed	the	presence	of	two	
singlets	for	thiomethylene	protons	(Scheme	4).	
	
3.2.	Antimicrobial	activity	
	
Compounds	 tested	 for	 their	 activities	 against	 bacteria	
Gram(+)	 (Staphylcoccus	 aureus)	 and	 Gram(‐)	 bacteria	
(Escherichia	 coli)	 in	 addition	 to	 pathogenic	 fungi	 (Aspergillus	
flavus	 and	 Candida	 albicans).	 Measured	 results	 of	 the	
examination	of	antimicrobial	average	diameter	of	the	inhibition	
zones,	expressed	 in	mm,	and	shown	 in	Table	1.	The	 results	of	
the	 tests	 performed	 in	 all	 of	 the	 tested	 compounds	 show	
significant	 activities	 to	 combat	E.	coli	 and	S.	aureus,	while	 the	
vehicles	were	 only	 Compound	4	 and	11	moderately	 active	 to	
fight	 A.	 Flavus	 and	 C.	 albicans.	 However,	 the	 activities	 of	 the	
tested	 compounds	 are	 much	 lower	 than	 those	 factors,	 anti‐
fungal	and	anti‐bacterial	standard	used.	
	
4.	Conclusion	
	
Newly	 synthesized	 thieno[3,2‐d][1,3]thiazine	 nucleosides	
derivatives	 were	 thoroughly	 characterized	 and	 some	 of	 them	
exhibited	antimicrobial	activity.	
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